List of Tables
Table 1. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Competitive Situation by Manufacturers in 2025
Table 4. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease, Product Types and Applications
Table 12. Global Key Manufacturers of Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Companies by Tier (Tier 1, Tier 2, Tier 3), based on Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Region (K Units), 2021–2026
Table 18. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Region (2021–2026)
Table 19. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Region (K Units), 2027–2032
Table 20. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Region (2027–2032)
Table 21. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Region (US$ Million), 2021–2026
Table 22. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Region (2021–2026)
Table 23. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Region (US$ Million), 2027–2032
Table 24. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Region (2027–2032)
Table 25. North America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Country (K Units), 2021–2026
Table 27. North America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Country (K Units), 2027–2032
Table 28. North America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country (US$ Million), 2021–2026
Table 29. North America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Country (K Units), 2021–2026
Table 32. Europe Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Country (K Units), 2027–2032
Table 33. Europe Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Country (K Units), 2021–2026
Table 42. Latin America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Country (K Units), 2027–2032
Table 43. Latin America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue by Country (US$ Million), 2027–2032
Table 50. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units) by Type (2021–2026)
Table 51. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units) by Type (2027–2032)
Table 52. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Type (2021–2026)
Table 53. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Type (2027–2032)
Table 54. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Type (2021–2026)
Table 57. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Type (2027–2032)
Table 58. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Price (US$/Unit) by Type (2021–2026)
Table 59. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Price (US$/Unit) by Type (2027–2032)
Table 60. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units) by Application (2021–2026)
Table 61. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units) by Application (2027–2032)
Table 62. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Application (2021–2026)
Table 63. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Application (2027–2032)
Table 64. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Application (2021–2026)
Table 67. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Application (2027–2032)
Table 68. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Price (US$/Unit) by Application (2021–2026)
Table 69. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Price (US$/Unit) by Application (2027–2032)
Table 70. Fujirebio Company Information
Table 71. Fujirebio Description and Business Overview
Table 72. Fujirebio Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Fujirebio Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 74. Fujirebio Recent Developments/Updates
Table 75. Quanterix Company Information
Table 76. Quanterix Description and Business Overview
Table 77. Quanterix Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Quanterix Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 79. Quanterix Recent Developments/Updates
Table 80. People Bio Company Information
Table 81. People Bio Description and Business Overview
Table 82. People Bio Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. People Bio Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 84. People Bio Recent Developments/Updates
Table 85. Easund Bio-tech and Pharmakea Company Information
Table 86. Easund Bio-tech and Pharmakea Description and Business Overview
Table 87. Easund Bio-tech and Pharmakea Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Easund Bio-tech and Pharmakea Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 89. Easund Bio-tech and Pharmakea Recent Developments/Updates
Table 90. MagQu Company Information
Table 91. MagQu Description and Business Overview
Table 92. MagQu Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. MagQu Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 94. MagQu Recent Developments/Updates
Table 95. Solgent Company Information
Table 96. Solgent Description and Business Overview
Table 97. Solgent Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Solgent Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 99. Solgent Recent Developments/Updates
Table 100. Sysmex Company Information
Table 101. Sysmex Description and Business Overview
Table 102. Sysmex Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sysmex Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 104. Sysmex Recent Developments/Updates
Table 105. Immuno-Biological Laboratories Company Information
Table 106. Immuno-Biological Laboratories Description and Business Overview
Table 107. Immuno-Biological Laboratories Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Immuno-Biological Laboratories Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 109. Immuno-Biological Laboratories Recent Developments/Updates
Table 110. Shenzhen Anqun Bioengineering Company Information
Table 111. Shenzhen Anqun Bioengineering Description and Business Overview
Table 112. Shenzhen Anqun Bioengineering Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Shenzhen Anqun Bioengineering Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 114. Shenzhen Anqun Bioengineering Recent Developments/Updates
Table 115. Amoneta Diagnostics Company Information
Table 116. Amoneta Diagnostics Description and Business Overview
Table 117. Amoneta Diagnostics Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Amoneta Diagnostics Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Product
Table 119. Amoneta Diagnostics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Distributors List
Table 123. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Customers List
Table 124. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Trends
Table 125. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Drivers
Table 126. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Challenges
Table 127. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease
Figure 2. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Share by Type: 2025 & 2032
Figure 4. Magnetic Particle Chemiluminescence Methods Product Picture
Figure 5. Enzyme-linked Immunoassay Methods Product Picture
Figure 6. Chemiluminescence Immunoassay Methods Product Picture
Figure 7. Dry Fluorescence Immunochromatography Methods Product Picture
Figure 8. Others Product Picture
Figure 9. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Share by Application: 2025 & 2032
Figure 11. Clinical Diagnosis
Figure 12. Research
Figure 13. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Size (US$ Million), 2021–2032
Figure 15. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales (K Units), 2021–2032
Figure 16. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Average Price (US$/Unit), 2021–2032
Figure 17. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Report Years Considered
Figure 18. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Share by Manufacturers in 2025
Figure 19. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Players: Market Share by Revenue in Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease in 2025
Figure 21. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Country (2021–2032)
Figure 24. North America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Country (2021–2032)
Figure 25. United States Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Country (2021–2032)
Figure 28. Europe Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Country (2021–2032)
Figure 29. Germany Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Region (2021–2032)
Figure 36. China Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Country (2021–2032)
Figure 44. Latin America Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease by Type (2021–2032)
Figure 55. Global Revenue Market Share of Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease by Type (2021–2032)
Figure 56. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease by Application (2021–2032)
Figure 58. Global Revenue Market Share of Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease by Application (2021–2032)
Figure 59. Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Price (US$/Unit) by Application (2021–2032)
Figure 60. Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
